What happens when you take turmeric tea with warfarin?
Turmeric (Curcuma longa) is the rhizome that gives curry its yellow color. Its main bioactive constituents are a group of curcuminoids, dominated by curcumin. Curcumin has a remarkably broad pharmacology in laboratory studies, including anti-inflammatory, antioxidant, antiproliferative, and notably antiplatelet and anticoagulant effects.
In in vitro and animal studies, curcumin has been shown to inhibit thrombin (a central enzyme in the clotting cascade), inhibit factor Xa, suppress platelet aggregation by reducing thromboxane B2 generation, and inhibit several CYP450 enzymes including CYP2C9 and CYP3A4. CYP2C9 is the principal enzyme responsible for metabolizing the more potent S-enantiomer of warfarin; inhibiting it raises warfarin levels.
The clinical signal comes from case reports collected by medicines regulators. New Zealand's Medsafe issued a safety communication in 2018 describing a patient who began taking a turmeric product while on stable warfarin and within a few weeks had an INR over 10, with bleeding risk in the dangerous range. The Australian Therapeutic Goods Administration has reported similar cases, and the UK MHRA has flagged turmeric as a herbal product warranting caution in patients on anticoagulants.
Importantly, the evidence is not unanimous. A clinical trial of Meriva (a phytosomal curcumin formulation) in stable warfarin patients did not detect a significant change in INR. The contradiction likely reflects differences in dose, bioavailability, formulation, individual genetic variation in CYP2C9, and concurrent medications.
Why is this important?
Warfarin's therapeutic window is narrow. An INR above 4 to 5 substantially increases bleeding risk; an INR of 8 to 10 is a medical emergency that can require vitamin K reversal and observation for bleeding. Because turmeric is widely viewed as a benign anti-inflammatory spice, patients often start taking it (or significantly increase intake by switching to a daily curcumin supplement, golden milk latte, or turmeric "shot") without telling their anticoagulation clinic.
The combination is especially dangerous when curcumin is taken in a high-bioavailability formulation. Curcumin in plain turmeric powder is poorly absorbed, with bioavailability under 1%. Modern supplements use piperine (a black pepper extract), liposomal delivery, phytosomes, micelles, or nanoparticles to increase systemic exposure five to twenty fold or more. A modest turmeric latte may be relatively safe, while a 1000 mg daily curcumin-piperine capsule can deliver effective drug-level exposure.
Patients on warfarin who also take any of the following may be at amplified bleeding risk when adding turmeric: aspirin, clopidogrel or other antiplatelets, NSAIDs, fish oil, garlic supplements, ginkgo, ginseng, vitamin E, dong quai, danshen, or any of the direct oral anticoagulants.
What should you do?
If you take warfarin, the safest approach is to keep turmeric intake to small, occasional culinary amounts (a pinch in a curry, a sprinkle in soup). Avoid daily turmeric tea, golden milk, turmeric shots, and curcumin supplements unless your prescriber explicitly approves.
If you have already been using a daily turmeric product on stable warfarin without issue, do not stop abruptly: a sudden discontinuation can cause the INR to drop and raise clotting risk. Instead, talk to your anticoagulation clinic, taper the turmeric gradually, and schedule INR checks during the transition.
If you choose to start or continue daily turmeric while on warfarin with your clinician's approval, hold the dose and formulation constant. Switching from a teaspoon of turmeric powder to a 500 mg standardized curcumin capsule is effectively a dose escalation of many times. Request an INR check within one to two weeks of any change and again at four weeks.
Watch for bleeding signs: nosebleeds, bleeding gums, easy bruising, pink or red urine, dark or tarry stools, vomiting blood or coffee-ground material, unusual headaches, joint swelling, or bleeding from cuts that takes longer than usual to stop. Any of these warrant an urgent INR check.
Which specific products are affected?
The drug side is warfarin (Coumadin, Jantoven) and other coumarin anticoagulants used internationally (acenocoumarol, phenprocoumon). The mechanism (antiplatelet effect plus CYP inhibition) is also potentially relevant to direct oral anticoagulants such as apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban (Lixiana), although clinical reports are sparse.
The turmeric side includes plain turmeric tea bags, golden milk lattes, turmeric and ginger shots, fresh turmeric root infusions, curcumin capsules (often standardized to 95% curcuminoids), high-bioavailability curcumin formulations (Meriva, BCM-95, Theracurmin, Longvida, NovaSol, CurcuWIN), turmeric and black pepper combination supplements, and many joint-health and inflammation blends.
The bottom line
Turmeric and curcumin can prolong INR and increase bleeding risk in patients on warfarin, with documented case reports of INRs above 10. Occasional culinary turmeric is generally fine, but daily turmeric tea and curcumin supplements should be avoided or used only with prescriber approval and tightened INR monitoring. The risk is amplified by high-bioavailability formulations and by concurrent use of other blood-thinning agents.